drugset / Trial / NCT04005365

Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer

NCT04005365

NaSingle-groupOpen-labelTreatment

Summary

At the cellular and animal level, we found that propranolol can inhibit the proliferation and invasion of gastric cancer cells. Further, we want to explore the efficacy and safety of propranolol in the treatment of gastric cancer patients.

Timeline

Start
2019-11-20
Primary completion
2020-06-01
Completion
2020-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule

Indications